17.06.2010 • News

Descartes Acquires Routing International

Descartes Systems Group, a federated global logistics network, acquired privately-held Belgian-based Routing International, a developer and distributor of optimized route planning solutions. Routing International's solutions join Descartes' MRM 2.0 solution suite, which combine optimized real-time planning with wireless mobile technology to manage resources in motion.

"The addition of Routing International's solutions and customers expands Descartes' MRM 2.0 size, reach and scope in Europe," said Daniel Verougstraete, vice president, MRM EMEA at Descartes and former CEO of Routing International. "Combined, we have an end-to-end product footprint and local operations to service small to large enterprises in Europe."

Since 1990, Routing International has specialized in optimized route planning for distribution-intensive organizations. The company's flagship solution suite, WinRoute, and dedicated consultants help enterprises of all sizes and across industries to optimize distribution planning to improve the productivity and performance of their operations.

Routing International's solutions enhance Descartes' MRM 2.0 suite of solutions in the areas of advanced routing algorithms, advanced geocoding, historical traffic support and complex moveable and multi-compartment routing for food service and fuel industries. Routing International's pan-European customer base adds more than 200 members to Descartes' federated Global Logistics Network (GLN).

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

On Demand | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read